FDA Grants AP Status for Lamotrigine ANDA078982 by Granules
The FDA has granted approval status (AP) for the ANDA078982 application for Lamotrigine submitted by Granules.
Asset / Drug
Drug and asset intelligence for Granules with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.